title: Comparison of sensory attributes and immediate efficacy of intranasal ciclesonide and fluticasone propionate in allergic rhinitis: a randomized controlled trial.
abstract: OBJECTIVE
  Intranasal corticosteroids (INCs) are the most effective modality for treating allergic rhinitis and their sensory attributes are important in patient compliance. This study aimed to compare the sensory attributes (scent, immediate taste, aftertaste, run down to throat, nose run off, soothing feel, nasal irritation, and urge to sneeze) and immediate response to the new intranasal steroid, ciclesonide (CIC), with fluticasone propionate (FLP) in allergic rhinitis.
  
  
  METHODS
  A randomized, double blind, single dose, crossover study was done with 74 patients presenting with acute allergic rhinitis. Eligible subjects were randomized in 1:1 ratio to one of the two treatment sequences - CIC followed by FLP or vice versa. Sensory attributes were assessed using a questionnaire to score each item on a seven-point Likert scale, immediately and 2 min after dosing. Total nasal symptom score (TNSS) was calculated to evaluate immediate efficacy 10 min after first drug administration. Overall preference was recorded 10 min after the second drug administration. Patients were queried about treatment emergent adverse events following study drug administration and also 24 h later over the phone.
  
  
  RESULTS
  Patients (58% males; pooled median age 32 years [Interquartile range, IQR, 25-41]; pooled median symptom duration 24 months [IQR 12-72]) preferred FLP over CIC nasal spray overall (55.41% vs. 25.68%, P = 0.007) and also with respect to attributes of scent, soothing feel, and nasal irritation. There was no statistically significant difference in immediate efficacy. Two patients reported mild headache following CIC first, while three felt mild headache, one dizziness, and one nasal congestion following FLP first administration. There were no delayed adverse events.
  
  
  CONCLUSIONS
  There was no difference in immediate outcome following use of either of the two INCs. FLP was preferred over CIC with respect to scent, soothing feel and nasal irritation, and also overall. There were no significant adverse events.
authors.affiliation: Department of Clinical Pharmacy, SGRRITS, Dehradun, Uttarakhand, India.
authors.forename: Jitendra
authors.initials: J
authors.lastname: Varshney
authors.forename: Himanshu
authors.initials: H
authors.lastname: Varshney
authors.forename: Sumanta Kumar
authors.initials: SK
authors.lastname: Dutta
authors.forename: Avijit
authors.initials: A
authors.lastname: Hazra
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D000068298:Fluticasone; D006801:Humans; D008297:Male; D009297:Nasal Mucosa / Q000187:drug effects* / Q000502:physiology; D011282:Pregnenediones / Q000008:administration & dosage*; D065631:Rhinitis, Allergic; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D013649:Taste / Q000187:drug effects* / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D000730:Androstadienes; D011282:Pregnenediones; D000068298:Fluticasone; C120481:ciclesonide
keywords: Allergic rhinitis; ciclesonide; fluticasone propionate; intranasal corticosteroid